DMAA

Drugs Made In America Acquisition Corp. - Ordinary Shares (DMAA)

About Drugs Made In America Acquisition Corp. - Ordinary Shares (DMAA)

Drugs Made In America Acquisition Corp. is a blank check company, which was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on May 23, 2024 and is headquartered in New York, NY.

Details

Daily high
$10.76
Daily low
$10.75
Price at open
$10.76
52 Week High
$10.76
52 Week Low
$10.23
Market cap
261.2M
Dividend yield
-
Volume
29,709
Avg. volume
13,563
P/E ratio
57.85

Drugs Made In America Acquisition Corp. - Ordinary Shares News

Details

Daily high
$10.76
Daily low
$10.75
Price at open
$10.76
52 Week High
$10.76
52 Week Low
$10.23
Market cap
261.2M
Dividend yield
-
Volume
29,709
Avg. volume
13,563
P/E ratio
57.85